Autism Research and Treatment / 2012 / Article / Tab 1

Research Article

Safety and Observations in a Pilot Study of Lenalidomide for Treatment in Autism

Table 1

Demographic and TNF-alpha (pg/ml) data for study subjects.

IDAgeCompletedBaseline TNF-alpha (pg/ml)Week 12 TNF-alpha (pg/ml)
CSFSerumCSFSerum

17Y103742420
212Y19*14*5*8*
37Y10115*7854
411Y991024527
58N157180106
66N232165
78N5558

𝑃 value*†0.0680.068

* 1: 1 diluted samples.
𝑃 values represent the results of the differences between baseline values and 6 and 12-month values using the Wilcoxon Signed Ranks Test.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.